Article by Daily Hive
Aurora Cannabis, one of Canada’s largest licensed producers, is teaming up with McGill University on an international medical research project to study the effects of CBD.
CBD (cannabidiol), is a non-intoxicating compound found in cannabis. It has been gaining traction in the past few years due to its therapeutic effects.
This study will focus on CBD oil as a therapy for chronic pain and related anxiety and depression.
“Based on our extensive experience with more than 60,000 registered Canadian patients, we believe CBD to be one of the most impactful medical compounds to become legally available to people in need of non-addictive therapies to treat pain,” CEO of Aurora, Terry Booth, stated in a press release.
“We are very pleased to be working with Aurora on this project,” said Dr. Gabriella Gobbi, a leading researcher at the Faculty of Medicine of McGill University.